# BIZENGRI

NDC: 83077-100
Generic name: Zenocutuzumab
Labeler / Manufacturer: Merus US, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20241204

FDA application: BLA761352

## Active ingredients

- ZENOCUTUZUMAB: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"83077-100"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=83077-100
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2a33e782-fc75-4dba-b77c-a44536ac13a5